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Background: Mobile communication has been found to improve antiretroviral therapy (ART) adherence among people living
with HIV. In an ongoing randomized clinical trial, 2 mobile communication strategies (ie, sending SMS text messages and
real-time medication monitoring [RTMM]) were used to improve adherence to ART among people living with HIV in Tanzania.
We noticed remarkable discrepancies between self-reported adherence and adherence recorded by SMS text messaging or RTMM
among some of the first trial participants.
Objective: Our objective was to describe these cases and the observed discrepancies in more detail, to serve as a useful illustration
of some of the challenges in using mobile health in resource-limited settings.
Methods: In an ongoing randomized trial, adults living with HIV from two HIV treatment centers in Tanzania who were
suspected of low levels of adherence were randomly assigned in a 1:1:1 ratio to receive (1) SMS text message reminders, (2) an
RTMM device, or (3) no additional intervention to standard HIV care. During bimonthly study visits, the participants self-reported
their level of adherence, received feedback about their level of adherence based on SMS text messaging or RTMM, and discussed
strategies to overcome adherence problems with nurses providing HIV care. For the purpose of this report, we selected people
living with HIV who had completed 5 follow-up visits and consistently reported more than 95% adherence, while SMS text
messaging or RTMM recorded lower than 75% adherence. The participants were invited for a short, face-to-face in-depth interview
to explore reasons for this discrepancy.
Results: At the time of this analysis, 26 participants had completed follow-up. Six of these evidenced the above-mentioned
discrepancies, with an average adherence of 46% based on SMS text messaging or RTMM, while self-reported adherence was
98%. Five of these 6 participants insisted that their adherence to ART was good, with 4 reporting that their adherence to properly
using the monitoring device was low. Three participants mentioned concerns about involuntary disclosure of HIV status as a
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main reason for low adherence to using the device. Two participants were still depending on other reminder cues despite receiving
SMS text message or RTMM reminders. Poor network coverage caused low adherence in 1 participant.
Conclusions: Psychosocial barriers were reported as importantly contributing to low adherence, both with respect to use of
ART and proper use of the adherence-monitoring device. This case series illustrates that when introducing new digital adherence
monitoring technology, researchers should consider psychosocial barriers and distinguish between adherence to device use and
adherence to treatment.
Trial Registration: Pan African Clinical Trials Registry PACTR201712002844286; https://tinyurl.com/y98q4p3l
(JMIR Form Res 2020;4(6):e14649) doi: 10.2196/14649
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Introduction
The Kilimanjaro region in Tanzania has an HIV prevalence rate
of 2.6%, which is lower than the country’s national prevalence
of 4.5% [1,2]. However, in this region, of those who receive
antiretroviral treatment (ART), only 47% of people living with
HIV have viral load suppression [1]. This suggests that
adherence to ART is often not optimal. Due to limited resources,
viral load is not routinely monitored, and consequently, timely
information about potential poor adherence to ART is not
available to HIV health care providers. Therefore, alternative
means of providing information about and interventions to
improve adherence to ART among people living with HIV are
needed [3]. Mobile phone technology can potentially help to
fill this need by using digital tools.
Several digital tools exist to monitor and intervene on adherence
to treatment. Real-time medication monitoring (RTMM) records
the date and time of every opening of a pillbox, a so-called
event. It sends this information in real time to a web platform
via the mobile network and is one of the existing technologies
for monitoring adherence. Reminder SMS text messages may
be sent to people living with HIV if the pillbox is not opened
on time [4]. Text messaging can also be used on its own as
another mobile phone technology to monitor and improve
adherence. The feasibility of text messages was found to have
mixed results, especially in rural areas [5,6]. Previous studies
have described several challenges of delivering RTMM and
SMS text messaging in resource-limited settings, such as poor
network coverage, power failure, and lack of interoperability
among network providers [5,7]. However, previous studies did
not describe in detail how such challenges affect the delivery
and use of mobile health (mHealth) strategies for treatment
adherence. Furthermore, despite these technical challenges, we
found that it was feasible and acceptable to monitor ART
adherence using RTMM among people living with HIV who
reside in the Kilimanjaro region [8].
Currently, we are conducting a randomized trial in which we
investigate the effect of mHealth strategies to improve adherence
to treatment among people living with HIV in the Kilimanjaro
region. People living with HIV are randomly assigned in a 1:1:1
ratio to receive (1) SMS text message reminders, (2) an RTMM
device, or (3) no additional intervention to standard HIV care.
During the trial, we encountered major discrepancies between
self-reported adherence and adherence reports generated by the
assigned mHealth intervention in several of our trial participants.
The objective of this report is to describe these cases and the
observed discrepancies in more detail to serve as a useful
illustration of some of the challenges researchers and health
care providers need to consider when intending to use mHealth
interventions to enhance adherence to ART in resource-limited
settings.
Methods
Patients Enrolled in the Randomized Controlled Trial
We first describe the trial and the interventions from where we
selected our patients. Our ongoing, parallel-group, 3-arm
randomized controlled trial (REMIND Study) has enrolled adults
living with HIV from the Kilimanjaro Christian Medical Centre
and the Majengo Health Centre, 2 specialized HIV care and
treatment centers in Moshi, Tanzania. By 2018, the Kilimanjaro
Christian Medical Centre served a total of 2800 people living
with HIV, while Majengo served 1200 people living with HIV.
In our larger randomized controlled trial study, 264 people living
with HIV were screened from both health centers. The study
nurses played a vital role in ensuring that potential participants
would understand the study. Written informed consent was
requested from participants, who were subsequently randomly
assigned equally to the study arms SMS text messaging, RTMM,
and control. The study was approved by the Kilimanjaro
Christian Medical College Research Ethics and Review
Committee and the National Health Research Ethics
Sub-Committee of Tanzania.
The main eligibility criteria for enrollment in the trial were that
the participant must currently be receiving ART and that there
is a suspicion of low adherence levels. The suspicion of low
adherence was based on the following criteria, as subjectively
judged by nurse counselors: (1) self-reported limited adherence,
(2) missed medication refill visit, (3) return of leftover
medication, or (4) other signs of nonadherence, including
continuous high viral loads. Exclusion criteria were hospital
admission or participation in other trials.
Intervention Arms
SMS Text Messaging
All participants who were enrolled in the SMS arm received 3
messages weekly on random days. The messages were in
Swahili and were similar for all patients. Thirty minutes before
the usual time of intake, an SMS text message was sent to
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remind patients to take their medication. One hour after the
usual time of intake, another SMS text message was sent with
the question “Did you take your medication?” The participant
was asked to reply, choosing from the following 3 options: (1)
Yes, I took it, (2) No, I did not take it, or (3) Not yet. The flow
of SMS text messages is depicted in Figure 1.
Figure 1. Flow of SMS text messages.
RTMM
All participants enrolled in the RTMM arm received a Wisepill
device (Wisepill Technologies) containing a third-generation
SIM card that sends signals to a central server each time the
device is opened, a so-called medication event and proxy for
medication intake. The signal contains information about the
time the device is opened, identification number of the device,
and technical information about the battery and strength of the
signal. If the device was not opened within 1 hour and 15
minutes after the usual time of intake, the participant receives
an SMS text message with a question about whether they took
their medication. The respondent could not respond to the text
message because the device does not have a function to support
incoming SMS text messages from users. Authorized members
of the study team could access the adherence report generated
by the device by signing in through the protected web portal.
Figure 2 presents the flow of communication between the
pillbox, central server, and a patient’s phone.
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Figure 2. Wisepill device architecture. (Source: Wisepill Technologies).
Feedback Session Procedure
Participants attended the care and treatment clinics every 2
months to receive standard HIV care and ART medication
refills, as per Tanzanian HIV treatment guidelines [6]. During
the visit, participants in the 2 intervention arms (SMS and
RTMM) received tailored feedback from the nurse counselor
about their medication adherence according to SMS or RTMM.
First, nurses asked participants whether they skipped any doses
of ART and to what extent they had been able to take all doses
of their ART in the past period. Next, the nurse provided
participants with a graph (generated from SMS or RTMM)
showing their level of adherence in percentages. Participants
were asked to comment on their adherence behavior displayed
on the graphs. Participants’ responses to the questions, their
answers, comments, and any explanations for potential
discrepancies between reported adherence and adherence based
on SMS text messaging or RTMM were registered. The
feedback was obtained using semistructured questionnaires and
recorded on case report forms.
Viral load was measured at enrollment in all study participants.
The lower detection limit of the viral load test was 20 copies/ml.
According to Tanzanian HIV treatment guidelines, viral loads
above 1000 copies/ml should be repeated after 3 months of
intensified counseling on adherence to treatment and those
below 1000 copies/ml should be repeated after a year. For
participants defined as “cases,” we retrieved the viral load from
their medical records at the beginning of the trial and at the end
of the follow-up period of the trial.
Case Selection and Interview
In this paper, we define cases as trial participants for whom
there was a major discrepancy between self-reported adherence
at the bimonthly study visit with the nurse and the adherence
as indicated by SMS or RTMM (ie, patients reporting good
adherence, 95% or higher, to the nurse, while SMS or RTMM
indicated poor adherence, 75% or lower). All participants
defined as cases were invited to an in-depth interview to explore
whether they had encountered any technical or practical
problems using SMS or RTMM. The interviews were conducted
by the study investigator provided with a topic guideline,
including perception of being monitored, technical issues, and
privacy concerns (ie, concerns that others would see the RTMM
device or read the content of the SMS text message, which could
disclose the participant’s HIV status). The topic list was
prepared by the study team.
Analysis
For each participant defined as a case, we calculated the average
level of adherence reported to the nurse at bimonthly study visits
and the participant’s level of adherence according to SMS text
messaging or RTMM over the 5 visits during the follow-up
period. For self-reported adherence, we directly asked how
many doses were missed, and from there we could calculate the
participant’s adherence level. For adherence according to SMS
text messaging or RTMM, we calculated the number of correct
intakes (measured by correct openings of the pillbox or by the
number of YES replies to the text message) divided by the
number of prescribed intakes. We report the participants’
comments on discrepancies between self-reported and
SMS/RTMM-based adherence, the explanations participants
gave for the discrepancies, and possible technical problems,




By November 2018, 26 participants of 249 who started with
the clinical trial had completed all 5 study clinic visits. Of the
26 participants, 12 were enrolled from Majengo sites and 14
from the Kilimanjaro Christian Medical Centre. As recorded
by SMS text messaging or RTMM, adherence rates were higher
than 75% in 20 participants. Adherence rates were lower than
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75% in 6, but these participants self-reported adherence rates
of 95% or higher and were thus considered to have major
discrepancies between self-reported and SMS/RTMM-based
adherence at each of the 5 study visits. For all cases, a median
of 46% adherence based on SMS or RTMM was recorded. Three
of these participants (all female) were enrolled in the SMS arm,
and 3 (1 female and 2 male) were enrolled in the RTMM arm.
All participants were on a twice-daily ART regimen. Two
participants in the RTMM arm and 1 in the SMS arm had
suppressed viral loads (Multimedia Appendix 1).
Case 1
The first case was a female living in urban Moshi who responded
to 73 (43%) of 168 SMS text messages with the question of
whether she took her medication. During study visits 1 to 5, the
participant confirmed that she received SMS text message
reminders on time, but she often did not respond to them; she
said, “I think I lacked commitment in responding to SMS.”
She felt depressed because she was separated from her family.
She had not expected that the nurses would find out that she
was not responding to the SMS text messages. After she was
confronted by the nurses about her low response rate to SMS
text messages, she tried to reply to them more often. She
mentioned that she had no difficulties taking her pills, despite
not replying to the SMS text messages. To improve adherence
to ART, she said,
I will set my phone alarm as extra reminder and
involve the caregiver as well.
She did not have concerns about privacy and answered,
I have a smartphone and it’s easy to disable SMS
notification as well as put a password. So, no one can
see or have access to my SMS.
Therefore, this participant reported high levels of adherence to
ART despite a low response rate to SMS text messages, and the
low response rate appeared to be related to feelings of
depression.
Case 2
Case 2 was an urban Moshi woman. Throughout visits 1 to 5,
186 SMS text messages were sent and delivered with the
question about whether she took her medication. However, only
95 (51%) SMS text messages were responded to with, “Yes, I
took it” and 91 (49%) SMS text messages were not responded
to.
When confronted by the nurses about her low response rate to
text messages during the feedback sessions, she mentioned that
the main challenge that hindered her in replying to SMS text
messages were her friends, who normally spent a lot of time
with her, especially in the evening. She explained,
My friends are always in my room, especially in the
evening; therefore, I am not feeling comfortable to
respond to SMS.
When asked whether she had disclosed her HIV status to them,
she said,
I’m scared to tell them, and with my age I still need
them around. Also, none of my friends will believe I
acquired HIV when I was born.
Of interest, she said, “Despite not responding to the SMS, I still
take my medication.”
This participant also reported high levels of adherence to ART
despite having a low response rate to SMS text messages. The
main reason for the low response rate to SMS text messages
was related to the fear of unwanted disclosure of her HIV status.
Case 3
In 2012, a 29-year-old woman living in urban Moshi started
ART. During visits 1 to 5, 186 SMS text messages were sent
and received, asking whether she took her medication. She only
replied to 53 (28%) text messages and did not respond to 133
(72%).
During feedback sessions with the nurses, she insisted, “I never
missed the medication intakes and I replied to the SMS.” She
also said,
I am surprised to see that I did not reply to all SMS.
I am wondering whether you are missing something
as I believe that I managed to take about 80% of my
pills.
However, in the interview with the study coordinator, she
confessed,
I was not honest during the feedback sessions with
the nurses. The reason for that is that I was depressed
because my sister found out I was receiving SMS to
remind me to take medication for HIV and then it
became even worse when she started telling my
neighbors that I will die soon.
When we asked if she thought the content of the SMS text
messages should be changed, she said,
I don’t have a problem with the content. Nowadays I
delete the SMS once I have replied to it so that no one
will read them in case they gain access to my phone.
For this participant, the main reason for not replying to SMS
was related to unwanted disclosure of HIV status and stigma
surrounding HIV.
Case 4
Case 4 was a 58-year-old female living in rural Moshi who
started ART in 2012 and was enrolled in the RTMM arm.
According to RTMM, her level of adherence during the first 2
study months was 47%. After the nurses showed her this level
of adherence during a feedback session, she said,
I never missed the medication intakes. I think the
RTMM was not working properly. Therefore, I want
to be provided with a new device.
The study nurse exchanged the old device with a new one. In
the next feedback session, her level of adherence according to
RTMM was still low, at 20%, despite her insistence that she
never missed a medication intake.
During the interview with the study investigator, the participant
mentioned that the device was easy to use, but charging it was
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a challenge because it did not have an alarm to indicate a low
battery. At the beginning of the study, this participant lived in
a rural area, where her adherence level was low, according to
RTMM. After 10 months, she moved to an urban area and the
device started to send daily signals, showing device openings
indicative of a high level of adherence. The participant
explained,
I have never missed my medication intakes; therefore,
I was surprised why the device was not recording the
openings. After I moved from my old house in the
village, the device started to record the openings, so
I thought the problem was network coverage.
The participant was happy to be monitored in real time, as it
made her feel cared for. Privacy concerns were not an issue for
this participant as she had disclosed her HIV status to her family.
For this participant, the main reason for the discrepancy between
self-reported adherence and adherence generated by the device
seemed to be related to adequate power, charging, and
availability of network coverage.
Case 5
Case 4 was a 33-year-old male who lives in urban Moshi. He
was enrolled in the RTMM arm and started ART in 2013.
According to RTMM, his level of adherence to ART was 57%,
on average, during the follow-up period of the study. This
participant explained that his main problem using the RTMM
device was concern about disclosure of his HIV status:
I have no problem with using the device except that
I did not disclose my HIV status to my children and
my co-workers. So sometimes it is difficult to open
the device when I am with them. However, I always
take my pills, which I kept outside the device.
This participant further explained,
I had difficulties carrying the device to my workplace
and since I’m working late sometimes, I sometimes
missed my evening dose of medication.
Thus, the main problems for this participant were related to
unwanted disclosure of HIV status and difficulties incorporating
the use of the device in daily activities.
Case 6
The sixth case was a 21-year-old man. With an average of 60%
ART adherence during the follow-up of the study, he
acknowledged missing his medication due to the lack of an
alarm on the RTMM device. He explained,
When I’m home with the device, I normally forget to
open it…Sometimes I wish the device should have an
alarm to notify me to open it for my medication intake.
He also said,
Currently I depend on other reminders, such as news
time hours and the alarm of the wall clock.
Before this participant enrolled in the study, he used to set an
alarm on his mobile phone as reminder to take his medication.
Now he says,
Since the device does not give an alarm, sometimes
I missed my medication intakes as there is nothing to
ring as alarm. However, as soon I receive the SMS
reminder, I take my medication.
Therefore, for this participant, the main reason for poor
adherence recorded by the device was that the normal strategy
that he used to remind himself to take his medication was
interrupted when entering the study, and he needed to adopt a
new strategy. As the SMS text message reminder comes late,
the participant might indeed be adherent but not on time.
Discussion
Principal Findings
This case series explored, in detail, 6 participants who had major
discrepancies between their self-reported and digitally monitored
adherence. This paper illustrates the challenges in using
mHealth, which emerged during an intervention trial using SMS
text message reminders and RTMM to improve adherence to
ART among people living with HIV in the Kilimanjaro region
in Tanzania. Interviews were conducted to determine whether
the discrepancies were triggered by difficulties in using the
interventions, poor network, power failures, potential stigma,
or other reasons.
One remarkable observation was that it is important to
distinguish between adherence to proper use of the digital
adherence monitoring device and adherence to treatment.
Patients enrolled in the SMS arm were expected to respond to
each question they received by SMS text message. However,
of all the SMS text messages that were delivered, on average,
only 46% postintake text messages were responded to. The
results showed that the postintake SMS text message was not
triggering the trial participants to respond well to the messages.
This finding seems to be in line with a previous study reporting
that implementation of mHealth interventions in low-income
countries can be complicated if end users have difficulties
adapting to new technologies due to lack of experience or
psychosocial barriers, which may lead to inadequate use of the
technology (ie, limited responding to messages or incorrect use
of the device for medication intake) [9].
Another remarkable finding was that several participants
considered using additional ways to remind themselves to take
their medication, such as using a phone alarm. We found this
striking, as sending electronic reminders to participants was
part of both intervention arms, yet participants needed additional
tools to help them remember to take their medicine on time.
One participant insisted that she took her medication even when
the RTMM device was replaced with a new one, but the new
device continued to indicate poor adherence. This discrepancy
turned out to be caused by the device not finding a network,
and it was therefore unable to properly transmit the signal to
indicate the medication intake event. As such, each time the
device was opened, it was not recorded in the system. However,
after the participant moved to an area with a network, the device
was able to send the signal on a daily basis. This underlines that
adequate network coverage is a prerequisite for the feasibility
of mHealth.
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In our previous study in the Kilimanjaro region [8], we also
encountered the problem of network instability due to bad
coverage that led to delays and failures in delivering reminder
SMS text messages among participants residing in several
remote villages. Despite the technical challenges that were
addressed by interviewing participants, we believe that using
mHealth and integrating it with the existing health system is
possible, but it would require stability of several factors such
as network coverage and power supply [9,10]. We therefore
suggest that future studies on mHealth interventions in
resource-limited settings may benefit from involving other
stakeholders, especially mobile network providers, since they
have a vital role in providing stable network coverage necessary
for delivering such interventions.
Psychosocial barriers, including mental health issues and lack
of social support, have been shown to result in poor use of
interventions due to fear of HIV disclosure within the family
or at workplaces. Findings from a previous study in Kenya
showed that SMS text messaging had better effect on treatment
adherence for those who received SMS text messages and who
reported a high level of social support [11]. Therefore, it is
important to take into account mental health issues when
applying digital tools by, for example, providing support through
messages or using the tool to increase communication about
mental health issues during clinic visits.
Privacy was a main issue for participants who did not disclose
their HIV status to others. This finding is consistent with that
of studies in South Africa and a study in Kenya that showed
that some participants had concerns that monitoring was
intruding on their privacy [12,13]. The use of neutral messages
that do not refer to topics related to sickness or medication could
overcome the problem of unwanted disclosure. In addition,
participants in the South African study had concerns that the
size and design of the pillbox would reveal their HIV status to
the community, especially when they needed to open it in the
vicinity of others. However, our pilot study in Kilimanjaro [8]
showed a different result, as most participants were happy with
the color and size of the device.
Case 6 illustrates the importance of ensuring that an intervention
intended to improve adherence does not interfere with a person’s
strategy to enhance their level of adherence. Despite that we
told our participants to keep using their normal ways of
reminding themselves to take their medication, this participant
decided to quit using his phone alarm. Although he declared
that the reminder SMS text message served as an alarm to him,
it did not lead to improved medication intake according to the
device. We cannot say that using the device hampered
medication intake, as this participant was judged to be
nonadherent at enrollment. Unfortunately, it was not clear why
this patient was not adherent. It is possible that the participant
was still not willing to disclose to the interviewer that he was
not taking his medication or not taking it on time.
Two participants had suppressed viral loads after being exposed
to the intervention for several months, despite having low levels
of adherence as indicated by responses to text messages or by
recorded RTMM device openings. It remains unclear whether
these participants were adherent to taking their medication but
nonadherent to the proper use of the intervention (ie, responding
to SMS text messages or opening the RTMM device). This
difficulty in distinguishing between adherence to treatment and
adherence to proper use of an intervention or device is not
unique to the 2 mHealth interventions that were used in this
study. Similar findings have been reported in 2 studies
conducted in Kenya [11,12]. Another explanation for the
suppressed viral loads might be that levels of adherence were
incorrectly recorded due to technical problems. To be able to
distinguish between true low adherence to treatment and low
adherence to the intervention combined with technical problems,
drug levels in the blood could give more insight. Because it was
not possible to measure plasma concentrations of antiretroviral
drugs in this study, we could not verify whether these
participants were nonadherent to their medication intake or
nonadherent to using their device.
Conclusion
This case series explored the reasons underlying major
discrepancies between self-reported adherence and digitally
monitored adherence that occurred in 6 participants in our
mHealth intervention trial. Based on our findings, we can make
a number of recommendations. First, network coverage at the
participant’s home must be ensured before implementation.
Second, neutral messages (eg, “Hello, this is your friend from
the REMIND Study. I hope you are doing well.”) should be
used to avoid unwanted disclosure of HIV status. Third,
participants should be advised to continue using their usual
reminder cues. Fourth, a triage system could be developed to
determine whether a patient is ready to use such mobile
interventions to prevent the paradoxical situation that an
intervention intended to improve treatment adherence actually
worsens adherence. Fifth, researchers should attempt to
distinguish between adherence to the use of a monitoring device
and adherence to treatment. Last, our findings serve as a
reminder of the paramount importance of psychosocial support
in the context of providing HIV treatment and care.
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